A Case Report of Isopropanol Ingestion During the SARS-CoV-2 Pandemic.

INTRODUCTION

Patients with substance use disorder may be particularly vulnerable to withdrawal-related complications during the SARS-CoV-2 (COVID-19) pandemic. Limited availability of alcohol and other substances coupled with decreased accessibility to substance use treatment poses a substantial risk to this population. Isopropanol, the active ingredient in rubbing alcohol, is widely available; thus, it may be used in times of scarcity.

CASE REPORT: We present a case of intentional isopropanol ingestion used as an ethanol surrogate within the setting of the COVID-19 pandemic.

CONCLUSIONS

Toxic alcohol ingestions are imperative considerations on the differential for the intoxicated patient particularly during resource-limited times.